DOCS - Doximity, Inc.
NYSE
->
Healthcare
->
Health Information Services
San Francisco,
United States
Type: Equity
DOCS price evolution
DOCS
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $123.09 | $108.4 | $306.73 | |
| Short term investments | $587.15 | $621.45 | $566.44 | |
| Net receivables | $97.58 | $97.22 | $92.92 | |
| Inventory | ||||
| Total current assets | $840.9 | $862.82 | $989.66 | |
| Long term investments | ||||
| Property, plant & equipment | $24.65 | $24.52 | $24.92 | |
| Goodwill & intangible assets | $96.32 | $97.38 | $98.58 | |
| Total noncurrent assets | $159.75 | $162.75 | $163.85 | |
| Total investments | $587.15 | $621.45 | $566.44 | |
| Total assets | $1000.65 | $1025.57 | $1153.51 | |
| Current liabilities | ||||
| Accounts payable | $1.88 | $0.71 | $0.58 | |
| Deferred revenue | $66.86 | $91.68 | $98.51 | |
| Short long term debt | $2.11 | $1.94 | $2.05 | |
| Total current liabilities | $104.76 | $123.18 | $132.69 | |
| Long term debt | $12.95 | $13.12 | $13.59 | |
| Total noncurrent liabilities | $31.27 | $30.92 | $30.03 | |
| Total debt | $15.06 | $15.05 | $15.63 | |
| Total liabilities | $136.03 | $154.1 | $162.72 | |
| Shareholders' equity | ||||
| Retained earnings | $61 | $85.4 | $225.16 | |
| Other shareholder equity | -$4.65 | -$8.93 | -$12.34 | |
| Total shareholder equity | $864.61 | $871.47 | $990.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Apr 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $158.03 | $112.81 | $66.39 | $66.39 |
| Short term investments | $682.97 | $685.3 | $76.14 | |
| Net receivables | $107.05 | $81.07 | $50.32 | $50.32 |
| Inventory | ||||
| Total current assets | $975.45 | $904.14 | $209.4 | $209.4 |
| Long term investments | ||||
| Property, plant & equipment | $25.1 | $9.57 | $8.94 | $7.6 |
| Goodwill & intangible assets | $99.78 | $26.82 | $28.51 | |
| Total noncurrent assets | $161.44 | $87.22 | $42.32 | $42.32 |
| Total investments | $682.97 | $685.3 | $76.14 | |
| Total assets | $1136.89 | $991.36 | $251.72 | $251.72 |
| Current liabilities | ||||
| Accounts payable | $1.27 | $0.46 | $1.51 | $1.51 |
| Deferred revenue | $105.44 | $84.98 | $83.49 | $83.27 |
| Short long term debt | $1.75 | $0.64 | $0.97 | |
| Total current liabilities | $139.51 | $111.28 | $102.04 | $102.04 |
| Long term debt | $13.88 | $0.45 | $0.28 | |
| Total noncurrent liabilities | $31.27 | $1.48 | $1.48 | $82.93 |
| Total debt | $15.64 | $1.09 | $1.25 | |
| Total liabilities | $170.77 | $112.76 | $103.52 | $103.52 |
| Shareholders' equity | ||||
| Retained earnings | $217.85 | $191.11 | $36.32 | $36.32 |
| Other shareholder equity | -$14.08 | -$15.29 | -$0.02 | -$0.02 |
| Total shareholder equity | $966.12 | $878.59 | $66.74 | |
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $135.28 | $108.47 | ||
| Cost of revenue | $12.19 | $13.15 | ||
| Gross Profit | $123.09 | $95.32 | ||
| Operating activities | ||||
| Research & development | $19.95 | $21.93 | ||
| Selling, general & administrative | $44.6 | $43.7 | ||
| Total operating expenses | $64.54 | $65.63 | ||
| Operating income | $58.55 | $29.68 | ||
| Income from continuing operations | ||||
| EBIT | $63.03 | $34.52 | ||
| Income tax expense | $15.08 | $6.12 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | $47.96 | $28.41 | ||
| Income (for common shares) | $47.96 | $28.41 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Apr 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $419.05 | $343.55 | $206.9 | $206.9 |
| Cost of revenue | $53.49 | $39.79 | $31.2 | |
| Gross Profit | $365.56 | $303.76 | $175.7 | $175.7 |
| Operating activities | ||||
| Research & development | $80.19 | $62.35 | $43.87 | |
| Selling, general & administrative | $160.27 | $127.88 | $78.53 | |
| Total operating expenses | $240.45 | $190.22 | $122.4 | $122.59 |
| Operating income | $125.11 | $113.54 | $53.3 | $53.3 |
| Income from continuing operations | ||||
| EBIT | $133.16 | $114 | $57.77 | |
| Income tax expense | $20.34 | -$40.78 | $7.56 | $7.56 |
| Interest expense | ||||
| Net income | ||||
| Net income | $112.82 | $154.78 | $50.21 | $50.21 |
| Income (for common shares) | $112.82 | $133.26 | $21.56 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $47.96 | $30.6 | $28.41 | $30.67 |
| Operating activities | ||||
| Depreciation | $3.03 | $3.14 | $3.14 | $3.25 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.77 | $13.45 | $14 | $12.99 |
| Total cash flows from operations | $50.05 | $12.9 | $57.2 | $46.64 |
| Investing activities | ||||
| Capital expenditures | -$1.32 | -$1.28 | -$1.56 | -$1.03 |
| Investments | $41.46 | -$48.82 | $118.89 | -$12.18 |
| Total cash flows from investing | $40.13 | -$50.1 | $117.33 | -$13.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$74.25 | -$159 | -$18.47 | -$10.39 |
| Net borrowings | ||||
| Total cash flows from financing | -$75.5 | -$161.12 | -$25.82 | -$11.86 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $14.69 | -$198.33 | $148.7 | $21.57 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Apr 2021 |
|---|---|---|---|---|
| Net income | $112.82 | $154.78 | $50.21 | $50.21 |
| Operating activities | ||||
| Depreciation | $12.31 | $6.2 | $6.13 | |
| Business acquisitions & disposals | -$53.5 | -$27.45 | ||
| Stock-based compensation | $47.83 | $31.44 | $7.25 | |
| Total cash flows from operations | $179.6 | $126.58 | $82.97 | $82.97 |
| Investing activities | ||||
| Capital expenditures | -$6.18 | -$5.7 | -$4.61 | |
| Investments | -$0.24 | -$635.47 | -$38.34 | |
| Total cash flows from investing | -$59.92 | -$640.57 | -$70.42 | -$70.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$70.64 | $565.21 | $6.88 | |
| Net borrowings | ||||
| Total cash flows from financing | -$74.46 | $560.41 | $5.41 | $5.41 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $45.22 | $46.42 | $17.96 | $17.96 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.18 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |